Nanoform has been accepted as a new member of Pharma Industry Finland (PIF) by the Board of its association.

Pharma Industry Finland promotes the operation and development of its member companies and influences the Finnish health policy. PIF’s lobbying work extends from Finland to the European decision-making forums.

Edward Hæggström, Nanoform CEO, said:

“We are delighted to join PIF and are looking forward to assisting them with their efforts to advance the health sector in Finland and internationally. One of our key aims is to improve the quality of patients’ lives and this partnership provides the opportunity to help us do that.”

“We warmly welcome our new member to the PIF Family. We are happy that our family is growing and with these kind of innovative companies. Research and innovation form the basis of all activities of the research-based pharmaceutical industry. There is plenty of work to do in this area to find more effective treatments for the patients and medical care to those diseases that cannot be cured yet,”

says Sanna Lauslahti, Managing Director at Pharma Industry Finland.